Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank A Corvino

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Marketing Health Services|July 9, 2005
Standards for satisfactionFrank A Corvino
Current Medical Research and Opinion|March 21, 2017
The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health recordsFrank A Corvino, David Oliveri, Amy L Phillips
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Anaphylaxis care guidelines and the effect on health care resource use in the United StatesT Ted Song, Duncan Brown, Ulrike Lehnigk, et al.
Future Oncology (London, England)|October 19, 2020
Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinomaGeorge P Kim, Andy Surinach, Frank A Corvino, et al.
Diabetes Care|June 1, 2014
Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort studyFlorent F Richy, Meritxell Sabidó-Espin, Sandra Guedes, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2017
Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USANaomi V Dahl, Robert F Kaper, William E Strauss, et al.
Pharmacotherapy|October 19, 2017
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic EvaluationKelly R Reveles, Jennifer L Backo, Frank A Corvino, et al.
Plos One|October 18, 2018
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational studyEric Gluck, H Bryant Nguyen, Kishore Yalamanchili, et al.
Journal of Managed Care & Specialty Pharmacy|August 3, 2015
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims AnalysisMeredith Y Smith, Meritxell Sabidó-Espin, Anton Trochanov, et al.
Leukemia & Lymphoma|May 10, 2017
Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromesAmy E DeZern, Gary Binder, Syed Rizvi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Marketing Health Services|July 9, 2005
Standards for satisfactionFrank A Corvino
Current Medical Research and Opinion|March 21, 2017
The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health recordsFrank A Corvino, David Oliveri, Amy L Phillips
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Anaphylaxis care guidelines and the effect on health care resource use in the United StatesT Ted Song, Duncan Brown, Ulrike Lehnigk, et al.
Future Oncology (London, England)|October 19, 2020
Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinomaGeorge P Kim, Andy Surinach, Frank A Corvino, et al.
Diabetes Care|June 1, 2014
Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort studyFlorent F Richy, Meritxell Sabidó-Espin, Sandra Guedes, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2017
Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USANaomi V Dahl, Robert F Kaper, William E Strauss, et al.
Pharmacotherapy|October 19, 2017
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic EvaluationKelly R Reveles, Jennifer L Backo, Frank A Corvino, et al.
Plos One|October 18, 2018
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational studyEric Gluck, H Bryant Nguyen, Kishore Yalamanchili, et al.
Journal of Managed Care & Specialty Pharmacy|August 3, 2015
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims AnalysisMeredith Y Smith, Meritxell Sabidó-Espin, Anton Trochanov, et al.
Leukemia & Lymphoma|May 10, 2017
Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromesAmy E DeZern, Gary Binder, Syed Rizvi, et al.
Pageof 2